ODAC members are not fortune-tellers, but FDA asked them to set development expectations for future PI3K inhibitors based on past experience with the class. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
